Computed Tomography (CT) Market By System Type (Low-slice, Mid-slice, High-slice); By Application (Oncology, Cardiology, Neurology); By Detector Technology (Solid-state, Photon-counting); By Workflow Type (Standalone, AI-enabled) – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032
The global Computed Tomography (CT) Market Market size was estimated at USD 9,070.00 million in 2025 and is expected to reach USD 13,234.42 million by 2032, growing at a CAGR of 6.50% from 2025 to 2032. Growth is anchored in rising cross-sectional imaging volumes across emergency care, cancer pathways, and chronic disease management, which continues to push providers to expand scanner fleets and refresh aging systems. Faster acquisitions, improved image reconstruction, and workflow automation are reinforcing utilization in high-throughput hospital settings and independent imaging centers, supporting steady replacement and upgrade demand.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
Computed Tomography (CT) Market Size 2025
USD 9,070.00 million
Computed Tomography (CT) Market, CAGR
6.50%
Computed Tomography (CT) Market Size 2032
USD 13,234.42 million
Key Market Trends & Insights
The CT Market is projected to expand at a CAGR of 6.50% during 2025–2032, supported by continued fleet modernization and higher scan volumes.
High-slice systems accounted for the largest share of 42.4% in 2025, reflecting demand for advanced protocols and faster throughput.
Oncology accounted for the largest application share of 31.4% in 2025, driven by staging, follow-up imaging, and therapy planning needs.
Asia Pacific led regional demand with a 36.7% revenue share in 2025, supported by expanding diagnostic capacity and large patient pools.
The market is expected to add USD 4,164.42 million in new revenue between 2025 and 2032, reflecting steady capital deployment into imaging infrastructure.
Segment Analysis
CT Market demand is shaped by a balance between high-performance system upgrades and operational efficiency priorities in imaging departments. Providers are focusing on reducing scan times, improving diagnostic confidence, and expanding multi-service line coverage, which sustains replacement cycles in hospitals and drives selective expansion in outpatient imaging networks. Procurement decisions increasingly emphasize total cost of ownership, uptime, and workflow standardization, especially where staffing constraints pressure scheduling and throughput.
Technology road maps are reinforcing differentiation through reconstruction algorithms, automation features, and detector improvements that support better tissue characterization and more consistent follow-up imaging. At the same time, buyers continue to prioritize compatibility with existing IT ecosystems, service coverage, and training needs to ensure stable day-to-day operations. These factors are shaping the relative traction of premium platforms versus more cost-optimized configurations.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
High-slice accounted for the largest share of 42.4% in 2025. The segment leads because advanced protocols in cardiac, neuro, and oncology pathways benefit from faster acquisitions and broader clinical versatility. Large tertiary hospitals and trauma centers often prioritize higher performance configurations to handle high patient turnover and complex cases. Replacement cycles also favor high-slice upgrades as departments seek consistent image quality and reduced rescans across a wide range of indications.
By Application Insights
Oncology accounted for the largest share of 31.4% in 2025. The segment remains dominant because CT is embedded in detection, staging, treatment planning, and response monitoring workflows across multiple cancer types. Repeat imaging requirements and standardized pathways raise utilization levels, supporting sustained scanner demand. Advanced reconstruction and dose-optimization approaches strengthen suitability for longitudinal imaging, which reinforces CT’s central role in cancer care delivery.
By Detector Technology Insights
Detector technology competition is increasingly defined by the push for higher diagnostic detail, spectral capability, and consistent image quality across patient types. Photon-counting is gaining attention where providers prioritize tissue differentiation and advanced clinical research pathways, especially in premium installations. Solid-state platforms remain the volume backbone because they are widely available, well understood by clinical teams, and supported by established service ecosystems. Procurement often reflects a tradeoff between next-generation performance aspirations and practical upgrade budgets.
By Workflow Type Insights
Workflow adoption is splitting between conventional standalone operation and AI-enabled environments focused on automation and standardization. AI-enabled systems are gaining momentum as imaging departments seek to reduce variability, streamline protocol selection, and accelerate reconstruction, particularly under staffing constraints. Standalone configurations remain common in cost-sensitive settings where core imaging throughput is the primary objective. Over time, broader enterprise integration and service analytics are expected to raise the strategic value of AI-enabled platforms.
Computed Tomography (CT) Market Drivers
Rising imaging volumes across acute and chronic care
Higher utilization in emergency care, oncology care pathways, and chronic disease management continues to increase demand for CT capacity. Hospitals seek shorter scan times and fewer repeat exams to improve throughput and reduce bottlenecks. Broader use of CT in triage and complex diagnostic workups supports consistent scanner use across departments. Replacement and expansion decisions often reflect the need to maintain service levels and reduce scheduling backlogs.
For instance, Siemens Healthineers’ SOMATOM X.ceed system integrates 0.25-second gantry rotation speed and a 2,000-slice reconstruction per second capability, enabling up to 20% faster workflow in multi-patient emergency departments.
Technology refresh cycles and performance upgrades
Health systems are upgrading installed bases to improve diagnostic confidence, streamline protocols, and support advanced applications. Faster acquisitions, improved reconstruction, and better motion management expand suitability for challenging patient profiles. High-performance configurations can enable more consistent imaging across multi-region protocols, supporting operational efficiency. These upgrade benefits strengthen the replacement case even when budgets are constrained, especially for high-volume centers.
For instance, GE HealthCare’s Revolution Apex platform employs Deep Learning Image Reconstruction (DLIR) algorithms that deliver up to 82% noise reduction and 30% quicker post-processing, facilitating high-quality imaging even with lower radiation doses.
Infrastructure investment in emerging healthcare markets
Imaging capacity buildout in developing regions supports new installations and expanded access to advanced diagnostics. Public and private investment in hospitals and diagnostic networks increases procurement activity, particularly where patient volumes are rising. Growing oncology and cardiovascular service lines also raise demand for reliable cross-sectional imaging. As facilities expand, buyers often prioritize scalable platforms with dependable service support and training resources.
Radiology departments face pressure to do more with limited staffing, making operational efficiency a primary purchasing driver. Automation features, protocol guidance, and reconstruction improvements support more predictable turnaround times. Standardized workflows can help reduce variability in image quality across sites and operators. These needs reinforce interest in AI-enabled platforms and enterprise integration that supports fleet-level productivity improvements.
Computed Tomography (CT) Market Challenges
Cost remains a persistent constraint for many buyers, especially when budgets must cover both scanner procurement and long-term service commitments. Procurement processes can be lengthy due to tender requirements, site readiness, and multi-stakeholder evaluation, which may delay deployments. Training and workflow change management can also slow adoption of advanced features, limiting near-term value realization. Service availability, uptime expectations, and parts logistics remain critical factors that can influence vendor selection.
Utilization pressure can create competing priorities between throughput and image quality, particularly in high-volume settings where scheduling constraints are severe. Facilities may also face IT integration complexity across PACS, RIS, and enterprise data environments, creating friction during commissioning. Radiation dose optimization expectations require continuous protocol governance and staff engagement. These factors can increase operational burden and elevate total cost of ownership concerns.
For instance, GE HealthCare’s Smart Subscription platform integrates CT fleet analytics with automatic dose-tracking modules, enabling real-time monitoring of up to 40 scanners across sites and reducing average patient radiation exposure by 22% under DoseWatch monitoring workflows.
Computed Tomography (CT) Market Trends and Opportunities
AI-enabled reconstruction and protocol automation are becoming more central to differentiation as providers seek consistent image quality and faster turnarounds. Vendors are positioning smart workflows to reduce variability across operators and sites, which supports multi-facility imaging networks. Integration with enterprise imaging and analytics platforms is also rising in importance as health systems focus on fleet productivity and uptime. These capabilities create opportunities for premium upgrades and software-led value expansion.
For instance, vendor-agnostic deep-learning reconstruction such as ClariCT.AI has been trained on over 1 million CT images across 24 scanner models and 2,100 scan/reconstruction condition combinations to standardize noise and resolution performance regardless of site-specific protocols.
Photon-counting adoption is emerging as an opportunity in premium segments, particularly where providers pursue advanced tissue characterization and spectral imaging applications. Research-focused hospitals and flagship centers can serve as adoption catalysts that shape broader procurement interest. Vendors can expand opportunity by pairing next-generation detector platforms with clear clinical use cases and workflow benefits. Over time, localized manufacturing and supply chain resilience can further improve competitiveness in high-growth regions.
Regional Insights
North America
North America accounted for 27.2% of CT Market revenue in 2025. Demand is supported by high imaging utilization, strong replacement cycles, and ongoing emphasis on operational efficiency in radiology departments. Large integrated delivery networks often prioritize workflow standardization and predictable uptime to manage high patient volumes. Investments also reflect a focus on advanced protocols in cardiac, neuro, and oncology imaging service lines.
Europe
Europe captured 19.1% of the CT Market in 2025. Procurement activity is shaped by structured purchasing processes, strong emphasis on dose management, and cost-effectiveness considerations. Hospital modernization programs and outpatient imaging growth support steady replacement demand, especially for systems that can improve throughput without compromising diagnostic consistency. Service coverage, training, and IT interoperability remain key selection factors.
Asia Pacific
Asia Pacific led the CT Market with a 36.7% share in 2025. Capacity expansion across hospitals and diagnostic networks continues to drive installations, supported by rising care demand and broader access initiatives. Buyers often balance performance needs with affordability, creating space for both premium upgrades and cost-optimized configurations. Growth is reinforced by expanding oncology care delivery and increasing diagnostic throughput requirements.
Latin America
Latin America represented 12.1% of CT Market revenue in 2025. Demand is supported by modernization of imaging fleets in urban centers and the expansion of private diagnostic networks. Buyers frequently prioritize reliable service support and predictable operating costs, which can influence vendor positioning. Public procurement cycles and financing constraints can create uneven demand patterns across countries and care settings.
Middle East & Africa
The Middle East and Africa accounted for 4.9% of the CT Market in 2025. Growth is tied to hospital infrastructure investment, diagnostic center expansion, and rising burden of chronic disease. Procurement often emphasizes system reliability, service response times, and training to ensure stable operations. Concentrated demand in leading cities and referral hospitals supports targeted adoption of higher-performance configurations.
Competitive Landscape
Competition in the CT Market is shaped by portfolio breadth, clinical performance, workflow efficiency features, and service capabilities. Vendors differentiate through reconstruction performance, automation tools, and integration with enterprise imaging ecosystems. Sales strategies often combine capital equipment offerings with service contracts and software-led upgrades to strengthen lifetime value. Installed base strength and long-term relationships with hospital systems also influence replacement-cycle wins.
Siemens Healthineers positions strongly through broad imaging portfolios and continued focus on next-generation CT capabilities and workflow productivity. Product strategies commonly emphasize image quality consistency, protocol efficiency, and clinical versatility across high-volume service lines. Enterprise integration and service infrastructure can reinforce customer retention in multiyear replacement cycles. This approach aligns with buyer priorities centered on throughput, standardization, and dependable uptime.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In April 2026, Nano-X Imaging’s U.S. subsidiary, Nanox Impact, signed a regional distribution agreement with Integrity Medical Service, marking a partnership update covered in CT imaging industry news.
In March 2026, GE HealthCare reported that its Photonova Spectra photon-counting CT system received U.S. FDA clearance, expanding the company’s advanced CT portfolio in the U.S. market.
In February 2025, Siemens Healthineers presented its mobile stroke unit solution built around the Somatom On.site CT scanner and the Stroke Connect digital platform, aimed at reducing time to stroke diagnosis and treatment decisions.
In March 2025, Canon Medical Systems announced regulatory clearance for major AI-driven enhancements to its Aquilion ONE/INSIGHT Edition CT scanner, including the Precise IQ Engine and SilverBeam filter technology.
In November 2024, Philips received U.S. FDA clearance for the Spectral CT 7500 RT, a CT system designed to combine spectral data with respiratory gating for radiation therapy planning.
Report Scope
Report Attribute
Details
Market size value in 2025
USD 9,070.00 million
Revenue forecast in 2032
USD 13,234.42 million
Growth rate (CAGR)
6.50% (2025–2032)
Base year
2025
Forecast period
2026-2032
Quantitative units
USD million
Segments covered
By System Type, By Application, By Detector Technology, By Workflow Type
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies profiled
Siemens Healthineers; GE HealthCare; Philips; Canon Medical; United Imaging; Fujifilm; Neusoft; Hitachi; Samsung Medison; Carestream
No.of Pages
334
Segmentation
By System Type
Low-slice
Mid-slice
High-slice
By Application
Oncology
Cardiology
Neurology
By Detector Technology
Solid-state
Photon-counting
By Workflow Type
Standalone
AI-enabled
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
1. Introduction
1.1 Report Description
1.2 Purpose of the Report
1.3 USP & Key Offerings
1.4 Key Benefits for Stakeholders
1.5 Target Audience
1.6 Report Scope
1.7 Regional Scope
2. Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
15.3.2 GE HealthCare
15.3.3 Philips
15.3.4 Canon Medical
15.3.5 United Imaging
15.3.6 Fujifilm
15.3.7 Neusoft
15.3.8 Hitachi
15.3.9 Samsung Medison
15.3.10 Carestream
16. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the Computed Tomography (CT) Market size and forecast?
The CT Market was valued at USD 9,070.00 million in 2025. The market is expected to reach USD 13,234.42 million by 2032.
What is the growth rate for the CT Market?
The CT Market is projected to grow at a CAGR of 6.50%. The forecast period covered is 2025–2032.
What is the largest segment in the CT Market?
High-slice is the leading system type, with a 42.4% share in 2025. The lead reflects demand for higher performance and throughput.
What factors are driving growth in the CT Market?
Higher imaging volumes, technology refresh cycles, and workflow efficiency needs are key drivers. Infrastructure expansion in emerging markets is also supporting installations.
Which companies are leading in the CT Market?
Key participants include Siemens Healthineers, GE HealthCare, Philips, and Canon Medical. Other notable players include United Imaging, Fujifilm, Neusoft, Hitachi, Samsung Medison, and Carestream.
Which region leads the CT Market?
Asia Pacific is the leading region with a 36.7% share in 2025. Regional leadership is supported by capacity expansion and rising diagnostic demand.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global contact lenses market was valued at USD 20,139.25 million in 2024 and is projected to reach USD 38,112.81 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.3% during the forecast period.
US Ultraviolet disinfection equipment Market was valued at USD 572.8 million in 2024 and is anticipated to reach USD 1611.2 million by 2032, growing at a CAGR of 13.8% during the forecast period.
The AI-based digital pathology market was valued at USD 1,093.72 million in 2024 and is projected to reach USD 2,069.83 million by 2032, expanding at a CAGR of 8.3% during the forecast period.
The Proliferative Diabetic Retinopathy Market size was valued at USD 2,499 million in 2024 and is anticipated to reach USD 4677.35 million by 2032, at a CAGR of 8.15 % during the forecast period.
Electronic Stethoscope Market size was valued USD 234 Million in 2024 and is anticipated to reach USD 511.77 Million by 2032, at a CAGR of 10.3% during the forecast period.
Emergency Hospital Bed market size was valued at USD 1,847 million in 2024 and is anticipated to reach USD 2,413.79 million by 2032, growing at a CAGR of 3.4% during the forecast period.
The global Digital Neurotherapeutics Market size was estimated at USD 2,965.30 million in 2025 and is expected to reach USD 8,310.95 million by 2032, growing at a CAGR of 18.74% from 2025 to 2032.
The global Digital Immunohistochemistry Market size was estimated at USD 1,850.65 million in 2025 and is expected to reach USD 3,514.20 million by 2032, growing at a CAGR of 11.28% from 2025 to 2032.
The global Digital Dentistry Market size was estimated at USD 8,120.40 million in 2025 and is expected to reach USD 14,128.77 million by 2032, growing at a CAGR of 9.67% from 2025 to 2032.
The global Diathermy Equipment Market size was estimated at USD 482.63 million in 2025 and is expected to reach USD 688.89 million by 2032, growing at a CAGR of 6.11% from 2025 to 2032.
The global Dialysis Concentrate Market size was estimated at USD 2,186.74 million in 2025 and is expected to reach USD 2,991.24 million by 2032, growing at a CAGR of 5.36% from 2025 to 2032.
The global Diagnostics Enzyme Market size was estimated at USD 3,214.59 million in 2025 and is expected to reach USD 4,972.17 million by 2032, growing at a CAGR of 7.54% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
